The Future of Disease Detection


  • Characterised by elevated breath acetone levels. Researchers can use this biomarker as a possible screening tool.
  • Current monitoring devices are mostly based on blood glucose analysis. The development of alternative devices that are non-invasive, inexpensive, and provide easy-to-use breath analysis could completely change the paradigm of self-monitoring diabetes.
  • The test detects ‘ketones’ which accumulate in the body when insulin levels are low.
  • People with diabetes frequently have heart disease and stroke which can lead to risk factors associated with cardiovascular and cerebrovascular disease, the leading cause of diabetes-related death


  • 382M global patients. By 2035, 592M (1 in 10).
  • Type 2 diabetes mellitus increased by 30.5% between 2001 and 2009 in children and adolescents. Nearly 50% of all childhood diabetes.

“Current testing for diabetes requires a blood test which can be traumatic for children.”